Artemisinin derivative

4 marketed 2 in Phase 3

This page covers all Artemisinin derivative drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Plasmodium parasites (multiple targets including heme and parasite proteins), Malaria parasite heme; potential cancer cell apoptosis pathways, Plasmodium heme and iron-dependent mechanisms.

Targets

Plasmodium parasites (multiple targets including heme and parasite proteins) · Malaria parasite heme; potential cancer cell apoptosis pathways · Plasmodium heme and iron-dependent mechanisms · Parasite proteins (non-specific alkylation via reactive oxygen species) · Plasmodium heme-dependent activation · Heme iron (parasite-derived); multiple parasite proteins and membranes

Marketed (4)

Phase 3 pipeline (2)